Organon in the sights of Sun Pharma: Is the big pharmaceutical deal coming now?

Organon is a global pharmaceutical company that focuses on women's health as well as established medications and so-called biosimilars. The company was formed in 2021 as a spin-off from Merck & Co. and pursues a business model with three central pillars: women's health, established brand medications, and biosimilars. Biosimilars are imitator products of biotechnologically manufactured medicines that come onto the market after the patent of the original drug has expired. Unlike classic generics, they are not identical due to the complex biological...